Divis Labs earmarks Rs 15 bn for capex as greefield Kakinada project stalls - Business Standard

Business Standard
Divis Labs earmarks Rs 15 bn for capex as greefield Kakinada project stalls
Business Standard
Active pharmaceutical ingredients (APIs) and drug intermediates maker Divis Laboratories Limited is creating additional capacities by spending as much as Rs 15 billion at its existing facilities in the next 15 months to more than make up for the ...and more »